Skip to main content

 Related scientific articles (all)

A Randomized Study of Interferon a-2b Versus No Treatment as Consolidation After High Dose Therapy and Autologous Stem Cell Transplantation for Patients With Relapsed Lymphoma.

Authors : Bosly A, Grigg A, Holte H, Gisselbrecht C, Radford J, Rossi A, Lopez-Guillermo A, Trneny M, Sebban C, Hagberg H, Leal da Costa F, Colombat P, Bron D, Coiffier B
Year : 2013
Journal : Oncologist
Volume : 18(11)
Pages : 1189

Rational approach of leucocytosis in adults].

Authors : Bron D
Year : 2013
Journal : Rev Med Brux
Volume : 34(4)
Pages : 339-42

Diagnosis and follow-up of monoclonal gammopathies of undetermined significance; information for referring physicians.

Authors : Caers J, Vekemans MC, Bries G, Beel K, Delrieu V, Deweweire A, Demuynck H, De Prijck B, De Samblanx H, Kentos A, Meuleman N, Mineur P, Offner F, Vande Broek I, Van Droogenbroeck J, Vande Velde A, Wu KL, Delforge M, Schots R, Doyen C
Year : 2013
Journal : Ann. Med.
Volume : 45(5-6)
Pages : 413-22

The impact of molecular biology techniques on the management of newly diagnosed chronic myeloid leukemia patients in chronic phase. A review.

Authors : Lewalle P, Martiat P
Year : 2013
Journal : Transfus. Apher. Sci.
Volume : 49(2)
Pages : 116-9

Therapeutic drug monitoring of posaconazole in patients with acute myeloid leukemia or myelodysplasic syndrome: a bicentric study.

Authors : Vaes M, Hites M, Cotton F, Bourguignon AM, Csergo M, Rasson C, Ameye L, Bron D, Jacobs F, Aoun M
Year : 2012
Journal : Antimicrob. Agents Chemother.
Volume : 56(12))
Pages : 6298-303

Mastocytosis: revisited with new cytogenetic data.

Authors : Vaes M, Vereecken P, de Wind R, Andry G, Li R, Bron D
Year : 2012
Journal : Rev Med Brux
Volume : 33(1)
Pages : 12-21

Safety and Efficacy of Radioimmunotherapy with 90Yttrium-rituximab in Patients with Relapsed CD20+ B cell Lymphoma: A Feasibility Study

Authors : Vaes M, Bron D, Vugts DJ, Paesmans M, Meuleman N, Ghanem G, Vanderlinden B, Thielemans K, van Dongen GA, Flamen P, Muylle K
Year : 2012
Journal : J Cancer Sci Ther
Volume : 4(12)
Pages : 394-400

Molecular subclasses of breast cancer: how do we define them? The IMPAKT 2012 Working Group Statement.

Authors : Guiu S, Michiels S, André F, Cortes J, Denkert C, Di Leo A, Hennessy BT, Sorlie T, Sotiriou C, Turner N, van de Vijver M, Viale G, Loi S, Reis-Filho JS
Year : 2012
Journal : Ann Oncol
Volume : 23
Pages : 2997-3006

Association between the nuclear to cytoplasmic ratio of p27 and the efficacy of adjuvant polychemotherapy in early breast cancer.

Authors : Andre F, Conforti R, Moeder CB, Mauguen A, Arnedos M, Berrada N, Delaloge S, Tomasic G, Spielmann M, Esteva FJ, Rimm DL, Michiels S
Year : 2012
Journal : Ann Oncol
Volume : 23
Pages : 2059-2064

Molecular subclasses of breast cancer: how do we define them? The IMPAKT 2012 Working Group Statement.

Authors : Guiu S, Michiels S, André F, Cortes J, Denkert C, Di Leo A, Hennessy BT, Sorlie T, Sotiriou C, Turner N, van de Vijver M, Viale G, Loi S, Reis-Filho JS
Year : 2012
Journal : Ann Oncol
Volume : 23(12)
Pages : 2997-3006

HDAC isoenzyme expression is deregulated in chronic lymphocytic leukemia B-cells and has a complex prognostic significance.

Authors : Van Damme M, Crompot E, Meuleman N, Mineur P, Bron D, Lagneaux L, Stamatopoulos B
Year : 2012
Journal : Epigenetics
Volume : 7(12)
Pages : 1403-1412

Erratum to: Immune-Related Antigens, Surface Molecules and Regulatory Factors in Human-Derived Mesenchymal Stromal Cells: The Expression and Impact of Inflammatory Priming.

Authors : Najar M, Raicevic G, Fayyad-Kazan H, De Bruyn C, Bron D, Toungouz M, Lagneaux L
Year : 2012
Journal : Stem Cell Rev
Volume : 8(4)
Pages : 1286

A common language in neoadjuvant breast cancer clinical trials: proposals for standard definitions and endpoints.

Authors : Fumagalli D, Bedard PL, Nahleh Z, Michiels S, Sotiriou C, Loi S, Sparano JA, Ellis M, Hylton N, Zujewski JA, Hudis C, Esserman L, Piccart-Gebhart M
Year : 2012
Journal : Lancet Oncol
Volume : 13(6)
Pages : e240-8

MicroRNA profile of circulating CD4-positive regulatory T cells in human adults and impact of differentially expressed microRNAs on expression of two genes essential to their function.

Authors : Fayyad-Kazan H, Rouas R, Fayyad-Kazan M, Badran R, El Zein N, Lewalle P, Najar M, Hamade E, Jebbawi F, Merimi M, Romero P, Burny A, Badran B, Martiat P
Year : 2012
Journal : J. Biol. Chem.
Volume : 287(13)
Pages : 9910-22

Elucidating prognosis and biology of breast cancer arising in young women using gene expression profiling.

Authors : Azim HA, Michiels S, Bedard PL, Singhal SK, Criscitiello C, Ignatiadis M, Haibe-Kains B, Piccart-Gebhart M, Sotiriou C, Loi S
Year : 2012
Journal : Clin Cancer Res
Volume : 18(5)
Pages : 1341-51

Characterization and clinical evaluation of CD10+ stroma cells in the breast cancer microenvironment.

Authors : Desmedt C, Majjaj S, Kheddoumi N, Singhal SK, Haibe-Kains B, El Ouriaghli F, Chaboteaux C, Michiels S, Lallemand F, Journe F, Duvillier H, Loi S, Quackenbush J, Dekoninck S, Blanpain C, Lagneaux L, Houhou N, Delorenzi M, Larsimont D, Piccart-Gebhart M, Sotiriou C
Year : 2012
Journal : Clin Cancer Res
Volume : 18(4)
Pages : 1004-14

Gene modules and response to neoadjuvant chemotherapy in breast cancer subtypes: a pooled analysis.

Authors : Ignatiadis M, Singhal SK, Desmedt C, Haibe-Kains B, Criscitiello C, Andre F, Loi S, Piccart-Gebhart M, Michiels S, Sotiriou C
Year : 2012
Journal : J. Clin. Oncol.
Volume : 30(16)
Pages : 1996-2004

AMD3100 disrupts the cross-talk between chronic lymphocytic leukemia cells and a mesenchymal stromal or nurse-like cell -based microenvironment: preclinical evidence for its association with chronic lymphocytic leukemia treatments.

Authors : Stamatopoulos B, Meuleman N, De Bruyn C, Pieters K, Mineur P, Le Roy C, Saint-Georges S, Varin-Blank N, Cymbalista F, Bron D, Lagneaux L
Year : 2012
Journal : Haematologica
Volume : 97(4)
Pages : 608-615

MYC+ diffuse large B-cell lymphoma is not salvaged by classical R-ICE or R-DHAP followed by BEAM plus autologous stem cell transplantation.

Authors : Cuccuini W, Briere J, Mounier N, Voelker HU, Rosenwald A, Sundstrom C, Cogliatti S, Hirchaud E, Ysebaert L, Bron D, Soulier J, Gaulard P, Houlgatte R, Gisselbrecht C, Thieblemont C
Year : 2012
Journal : Blood
Volume : 119(20)
Pages : 4619-24

Inflammation and Toll-like receptor ligation differentially affect the osteogenic potential of human mesenchymal stromal cells depending on their tissue origin.

Authors : Raicevic G, Najar M, Pieters K, De Bruyn C, Meuleman N, Bron D, Toungouz M, Lagneaux L
Year : 2012
Journal : Tissue Eng Part A
Volume : 18(13-14)
Pages : 1410-8